PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New advances in genetic studies of Fanconi anemia patients

Published online in Blood, the journal of the American Society of Hematology

2011-03-03
(Press-News.org) An international consortium of researchers led by Universitat Autònoma de Barcelona (UAB) genetically characterises almost all Spanish patients and studies the clinical impact of the mutations. The study describes over 130 pathogenic mutations and the origins and world distribution of some of the most frequent mutations. The predominant genetic mutation originated in Europe thousands of years ago and later migrated to America. The Canary island of La Palma and Brazil, with a high prevalence of the disease, were two areas in which the mutation spread widely.

A consortium of thirty-two researchers worldwide, led by Dr Jordi Surrallés, professor of the Department of Genetics and Microbiology at Universitat Autònoma de Barcelona (UAB) and member of the Centre for Biomedical Network Research on Rare Diseases (CIBERER), genetically and clinically characterised almost all Spanish patients suffering from Franconi anaemia, a rare disease affecting one in every 500,000 persons and which is characterised by severe anaemia in children, congenital malformations and a high predisposition to cancer.

A hundred people in Spain suffer from Fanconi anaemia; 80% of these present mutations in the FANCA gene. In the research, 90% of these patients were studied, as well as patients in Brazil, Mexico, Argentina, Peru, United States, United Kingdom, Portugal, Germany, Pakistan and Nigeria.

The research includes characterisation of over 130 pathogenic mutations in the FANCA gene, present in two of every three cases in almost all of the countries analysed, as well as the study of the origin and world distribution of some of the most frequent mutations. The mutation predominating in Spain and in the rest of countries is an ancestral mutation of Indo-European origin which spread throughout Europe thousands of years ago and which reached America across the Atlantic, producing founder effects in areas such as La Palma, with a high prevalence of the disease, and Brazil, where half of all patients share the same gene mutation.

Finally, researchers analysed the effects of the genetic mutations and their clinical impacts. Results indicate that these mutations provoke the absence or dysfunction of FANCA protein, which prevent it from reaching the cell nucleus and activating a DNA repair pathway necessary for genomic stability. This in turn brings about cell death - producing anaemia and abnormal tissue functions - or causes them to develop into tumours. For this reason the study of genes involved in Fanconi anaemia is essential to understand the factors which protect the general population from cancer.

Researchers verified that the fact that mutation produces protein absence or dysfunction does not determine the clinical evolution of anaemia or the severity of the malformative syndrome.

Dr Jordi Surrallés highlights the importance of the study carried out given that results will have significant applications in the diagnosis, prognosis and evolution of this rare disease. For example, several of the mutations described in the article served to carry out prenatal and even pre-implant diagnoses follow by the selection of healthy and compatible embryos, with the aim of using blood from the umbilical cord for bone marrow transplants to cure siblings.

INFORMATION:

Participating in the research were eleven hospitals in Spain and Portugal, two of which are UAB-affiliated hospitals (Sant Pau Hospital and Vall d'Hebron University Hospital) and several national and international research and university centres: CIEMAT (Centre for Energetic, Environmental and Technological Research), CNIO (National Cancer Research Centre), CIBERER, University of Wurzburg, The Rockefeller University, New York, and VU University Medical Center, Amsterdam.

Through its Genome Instability and DNA Repair Group, directed by Dr Jordi Surrallés, UAB has become a worldwide leader in research carried out into Fanconi anaemia. In recent years it has contributed greatly to the further understanding of genetic mechanisms involved in the disease, to the improvement of diagnoses and advances in new therapies, both independently and with the collaboration of institutions such as CIEMAT, CIBERER and CRMB (Centre of Regenerative Medicine in Barcelona).

About Fanconi Anaemia

Fanconi anaemia is a rare hereditary disease which mainly affects the bone marrow and causes it to produce less blood cells. Treatment includes transplanting healthy blood stem cells from the bone marrow or umbilical cord of a compatible donor, if possible, a relative. Unfortunately, few patients can find a healthy and compatible donor.

It is however a crucial disease to biomedical research since it is associated with vital functions such as embryonic development, blood production and genetic predisposition to cancer.

Reference article: Origin, functional role and clinical impact of Fanconi anaemia FANCA mutations. Castella M, Pujol R, Callén E, Trujillo JP, Casado JA, Gille H, Lach FP, Auerbach AD, Schindler D, Benitez J, Porto B, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, Díaz de Heredia C, Olivé T, Sánchez de Toledo J, Badell I, Torrent M, Estella J, Dasí A, Rodríguez-Villa A, Gómez P, Barbot J, Tapia M, Molinés A, Figuera A, Bueren JA, Surrallés J. Blood. 2011 Jan 27. [Epub ahead of print]

END



ELSE PRESS RELEASES FROM THIS DATE:

Polishing the apple's popular image as a healthy food

2011-03-03
Scientists are reporting the first evidence that consumption of a healthful antioxidant substance in apples extends the average lifespan of test animals, and does so by 10 percent. The new results, obtained with fruit flies — stand-ins for humans in hundreds of research projects each year — bolster similar findings on apple antioxidants in other animal tests. The study appears in ACS's Journal of Agricultural and Food Chemistry. Zhen-Yu Chen and colleagues note that damaging substances generated in the body, termed free radicals, cause undesirable changes believed to ...

New growth inhibitors more effective in plants, less toxic to people

2011-03-03
WEST LAFAYETTE, Ind. - A Purdue University scientist and researchers in Japan have produced a new class of improved plant growth regulators that are expected to be less toxic to humans. Angus Murphy, a professor of horticulture, said the growth inhibitors block the transport of auxin, a plant hormone that, when transported throughout the plant, controls growth processes. Current growth regulators that inhibit auxin transport are inefficient because they also have hormonelike activity or affect other important plant processes. Current growth inhibitors also are often toxic. Growth ...

Alaric Flower Design's Flower Dresses Were a Huge Hit at NYC Couture Fashion Week

Alaric Flower Designs Flower Dresses Were a Huge Hit at NYC Couture Fashion Week
2011-03-03
On February 20th, Alaric Flower Design participated in their first Fashion Week at the Waldorf Astoria. They showcased three concept floral dresses called "The Arrangement Collection" and were very well-received. Alaric Flower Design's Lena Yelagina and Olga Meshcheryakova are familiar with style, being one of the top florists in Midtown Manhattan for over five years.  Their floral designs have been described as stylish, stunning, elegant, and classy: a combination of description often coveted in the fashion world.  They presented three ready-to-wear dresses created ...

Blood protein in lung cancer could improve diagnosis and treatment

2011-03-03
Scientists are reporting discovery of a protein in the blood of lung cancer patients that could be used in a test for the disease — difficult to diagnose in its earliest and most treatable stages — and to develop drugs that stop lung cancer from spreading. Their study appears in ACS's Journal of Proteome Research. In the report, Je-Yoel Cho and colleagues note that lung cancer is the leading cause of cancer deaths worldwide. Lung cancer is so deadly because of its tendency to spread — or metastasize — to distant sites in the body, such as the liver or the brain. Early ...

Hair dyeing poised for first major transformation in 150 years

2011-03-03
Technological progress may be fast-paced in many fields, but one mundane area has been almost left in the doldrums for the last 150 years: The basic technology for permanently coloring hair. That's the conclusion of an analysis of almost 500 articles and patents on the chemistry of permanent hair dyeing, which foresees much more innovation in the years ahead, including longer lasting, more-natural-looking dyes and gene therapy to reverse the gray. The article appears in ACS's journal Chemical Reviews. Robert Christie and Olivier Morel note that hair dye already is a multibillion ...

Does fluoride really fight cavities by 'the skin of the teeth'?

2011-03-03
In a study that the authors describe as lending credence to the idiom, "by the skin of your teeth," scientists are reporting that the protective shield fluoride forms on teeth is up to 100 times thinner than previously believed. It raises questions about how this renowned cavity-fighter really works and could lead to better ways of protecting teeth from decay, the scientists suggest. Their study appears in ACS's journal Langmuir. Frank Müller and colleagues point out that tooth decay is a major public health problem worldwide. In the United States alone, consumers spend ...

New treaty on search for life-saving medicines in remote areas

2011-03-03
Real-life scientists, whose work has overtones of Indiana Jones as they search for plants in remote areas of the world that could become the source of life-saving new medicines, are currently trying to figure out how a new international agreement on biodiversity will affect their work. That's the topic of an article in Chemical & Engineering News (C&EN), ACS's weekly newsmagazine. C&EN Associate Editor Carmen Drahl explains that environment ministers from 200 countries hammered out the agreement late last year. Called the Nagoya protocol, it extends a 1993 United Nations ...

Researchers focus on human cells for spinal cord injury repair

2011-03-03
For the first time, scientists discovered that a specific type of human cell, generated from stem cells and transplanted into spinal cord injured rats, provide tremendous benefit, not only repairing damage to the nervous system but helping the animals regain locomotor function as well. The study, published today in the journal PLoS ONE, focuses on human astrocytes – the major support cells in the central nervous system – and indicates that transplantation of these cells represents a potential new avenue for the treatment of spinal cord injuries and other central nervous ...

Combined molecular study techniques reveal more about DNA proteins

2011-03-03
CHAMPAIGN, Ill. — Illinois researchers have combined two molecular imaging technologies to create an instrument with incredible sensitivity that provides new, detailed insight into dynamic molecular processes. Physics professors Taekjip Ha and Yann Chemla and combined their expertise in single-molecule biophysics – fluorescence microscopy and optical traps, respectively – to study binding and unbinding of individual DNA segments to a larger strand. They and their joint postdoctoral researcher Matthew Comstock detail their technique in a paper published in the Feb. 20 ...

Flood-tolerant rice plants can also survive drought, say UC Riverside scientists

Flood-tolerant rice plants can also survive drought, say UC Riverside scientists
2011-03-03
RIVERSIDE, Calif. – Rice, which is sensitive to drought due to its high water requirement, is particularly vulnerable to how global climate change is altering the frequency and magnitude of floods and droughts. If rice plants' combined tolerance to flooding and drought could be improved, however, rice productivity could be protected and even substantially increased. Now plant scientists at the University of California, Riverside have made a discovery that can greatly benefit rice growers and consumers everywhere. The researchers have demonstrated in the lab and greenhouse ...

LAST 30 PRESS RELEASES:

Singles differ in personality traits and life satisfaction compared to partnered people

President Biden signs bipartisan HEARTS Act into law

Advanced DNA storage: Cheng Zhang and Long Qian’s team introduce epi-bit method in Nature

New hope for male infertility: PKU researchers discover key mechanism in Klinefelter syndrome

Room-temperature non-volatile optical manipulation of polar order in a charge density wave

Coupled decline in ocean pH and carbonate saturation during the Palaeocene–Eocene Thermal Maximum

Unlocking the Future of Superconductors in non-van-der Waals 2D Polymers

Starlight to sight: Breakthrough in short-wave infrared detection

Land use changes and China’s carbon sequestration potential

PKU scientists reveals phenological divergence between plants and animals under climate change

Aerobic exercise and weight loss in adults

Persistent short sleep duration from pregnancy to 2 to 7 years after delivery and metabolic health

Kidney function decline after COVID-19 infection

Investigation uncovers poor quality of dental coverage under Medicare Advantage

Cooking sulfur-containing vegetables can promote the formation of trans-fatty acids

How do monkeys recognize snakes so fast?

Revolutionizing stent surgery for cardiovascular diseases with laser patterning technology

Fish-friendly dentistry: New method makes oral research non-lethal

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

[Press-News.org] New advances in genetic studies of Fanconi anemia patients
Published online in Blood, the journal of the American Society of Hematology